Treatment Options for Performance Anxiety

First-Line Treatment: Cognitive-Behavioral Therapy (CBT)

The American Academy of Child and Adolescent Psychiatry recommends CBT as the psychological intervention with the highest level of evidence for treating anxiety disorders, including performance anxiety, targeting cognitive, behavioral, and physiological components 1
CBT typically requires 12-20 sessions for meaningful symptomatic and functional improvement, though briefer interventions may also be effective in primary care settings 1, 2
Key CBT elements for performance anxiety include education about anxiety, behavioral goal setting, self-monitoring, relaxation techniques, cognitive restructuring, graduated exposure, and problem-solving and social skills training 1
CBT can be delivered in individual face-to-face sessions, group therapy, computer-based interventions, or self-help approaches, with individual face-to-face sessions being the most common 2

Second-Line Treatment: Pharmacotherapy

The American College of Physicians recommends Selective Serotonin Reuptake Inhibitors (SSRIs) such as paroxetine for various anxiety disorders, including social anxiety disorder (performance anxiety) 3

Treatment Effectiveness

65.9% of psychological interventions for anxiety in primary care settings demonstrated effectiveness in reducing anxiety symptoms, with 77.8% of effective interventions maintaining treatment gains at follow-up 2, 4
Most primary care patients prefer psychological treatments for anxiety over medication, according to the Journal of Anxiety Disorders 5

Special Considerations

Combination therapy, combining CBT with appropriate medication, may provide optimal outcomes for severe cases, as recommended by the Annals of Internal Medicine 3
Systematic assessment using standardized anxiety rating scales can help track progress and optimize treatment, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 1

Common Pitfalls to Avoid

Relying solely on medication without addressing underlying cognitive and behavioral patterns can be ineffective, according to the Journal of Anxiety Disorders 5
Insufficient exposure practice or allowing avoidance behaviors to persist can hinder treatment progress, as noted by the Journal of the American Academy of Child and Adolescent Psychiatry 1
Focusing only on symptom reduction without addressing functional improvement can limit treatment outcomes, as recommended by the Journal of the American Academy of Child and Adolescent Psychiatry 1

First-Line Treatment for Anxiety in Outpatient Primary Care

Evidence-Based Treatment Algorithm

Most primary care patients prefer psychological treatments over medication, making CBT alignment with patient preferences a key advantage, with 65.9% of psychological interventions for anxiety in primary care demonstrating effectiveness in reducing anxiety symptoms 6, 7
Treatment gains are maintained at follow-up in 77.8% of effective interventions, and 72.7% of anxiety interventions also effectively reduce comorbid depressive symptoms 7
The American College of Cardiology is not relevant here, however, the Journal of Anxiety Disorders recommends integration of behavioral health providers into primary care teams via the Primary Care Behavioral Health (PCBH) model as the most promising implementation strategy 6, 8

Special Population Considerations

Medication is not optimal for certain subpopulations including pregnant women and elderly patients, making CBT particularly important for these groups, with a strength of evidence supporting CBT as the first-line treatment 6, 9

Common Pitfalls to Avoid

Anxiety remains undertreated in primary care, with only 28% of patients receiving potentially adequate pharmacotherapy or CBT at baseline, highlighting the need for increased treatment provision 6, 10
Longer intervention formats make translation into practice difficult, necessitating adaptation to primary care constraints, with a recommendation for brief psychological interventions 6, 7

Management of Anxiety in Primary Care

Core Provider Responsibilities

The American College of Physicians and other guideline societies recommend that healthcare providers distinguish between normal anxiety responses and pathological anxiety disorders that cause marked distress, functional impairment, or reduced quality of life 11
Anxiety disorders affect 15-20% of primary care patients, with subthreshold symptoms being equally or more common than diagnostic-level disorders, according to the American Psychological Association 11, 12
The primary goal is to improve overall functioning and health, not merely symptom reduction, as this is the foundation of the Primary Care Behavioral Health (PCBH) model, as stated by the American Academy of Family Physicians 13
Anxiety confers immense burden including functional impairment and reduced quality of life that must be addressed, as noted by the National Institute of Mental Health 11, 12

Intervention Strategies

Providers should actively intervene to lower anxiety symptoms through evidence-based psychological and pharmacological interventions, as recommended by the American Psychiatric Association 11
Behavioral health providers embedded in primary care deliver brief psychological interventions as part of the PCBH model, not just referrals, according to the American College of Physicians 13
Most primary care patients prefer psychological treatments over medication and are more likely to seek treatment in primary care than specialty mental health settings, as found by the American Psychological Association 12
Brief CBT adapted for primary care (ideally 6 or fewer sessions of 15-30 minutes) fits within the provider's scope, as stated by the American Academy of Family Physicians 13
Referral to specialty care is reserved for severe or long-standing symptoms requiring intensive treatment, not all psychotherapy, as recommended by the American Psychiatric Association 13
Consider self-help materials or computer-delivered interventions for mild symptoms in a stepped care approach, as suggested by the National Institute of Mental Health 14
Track progress using standardized anxiety rating scales and advance to higher intensity treatment (medication, longer therapy, or specialty referral) only if brief interventions fail, as recommended by the American College of Physicians 13, 14

Buspirone for Anxiety Treatment in Primary Care

Introduction to Buspirone Treatment

The American Academy of Family Physicians recommends brief CBT adapted for primary care, which can be delivered effectively within the primary care setting through integrated behavioral health models, with 65.9% of psychological interventions for anxiety demonstrating effectiveness in reducing anxiety symptoms 15
Most primary care patients prefer psychological treatments over medication, making CBT alignment with patient preferences a key clinical advantage, with 77.8% maintaining treatment gains at follow-up 15

Clinical Considerations for Buspirone Prescription

The National Institute of Mental Health suggests that buspirone is most appropriate for patients with generalized anxiety disorder who have failed or cannot tolerate SSRIs, particularly for anxious elderly patients, those with chronic anxiety, and patients with mixed anxiety/depression symptoms 15
The American College of Physicians recommends considering buspirone for patients in whom medication side effects are a concern, such as pregnant women, elderly patients, and those requiring daytime alertness, since it lacks sedation, dependence potential, and does not potentiate alcohol 15

Implementation of Buspirone Treatment in Primary Care

The Agency for Healthcare Research and Quality suggests integrating behavioral health providers into primary care teams via the Primary Care Behavioral Health (PCBH) model to deliver brief psychological interventions before medication, reserving buspirone and other medications for patients with moderate-to-severe symptoms who have not responded to brief psychological interventions 15

Evidence‑Based Recommendations for Anxiety Management in Primary Care

Patient Preferences and Expected Outcomes

Primary‑care patients overwhelmingly prefer psychological interventions over medication, with roughly two‑thirds favoring therapy and the majority maintaining therapeutic gains at follow‑up. This reflects strong patient‑centered demand for non‑pharmacologic care. 16
Anxiety‑focused interventions also produce substantial improvements in comorbid depressive symptoms, with more than 70 % of such treatments showing concurrent depression reduction. Integrated approaches therefore address both conditions efficiently. 16

Standardized Monitoring

Validated anxiety rating scales (e.g., GAD‑7 or Hamilton Anxiety Rating Scale) should be administered at baseline and at regular intervals to objectively track treatment response. Routine use enables timely identification of inadequate response. 16
If symptom reduction is less than 30 % by 6–8 weeks, clinicians should consider advancing to pharmacotherapy (e.g., an SSRI) or referring to specialty mental‑health services. This threshold aligns with evidence‑based treatment‑modification guidelines. 16

Cognitive‑Behavioral Therapy (CBT) as First‑Line Care

Brief, primary‑care‑adapted CBT (≤ 6 sessions of 15–30 minutes each) has demonstrated effectiveness and feasibility within the Primary Care Behavioral Health (PCBH) model. Evidence from pragmatic trials supports its use as the initial therapeutic modality. 17
When embedded behavioral‑health providers are available, patients should be referred for same‑day or next‑available brief CBT sessions. Immediate access maximizes early therapeutic benefit. 17
If on‑site CBT resources are lacking, stepped‑care options such as self‑help materials or computer‑delivered CBT programs are appropriate for mild anxiety presentations. This maintains adherence to evidence‑based, non‑pharmacologic first‑line care. 17

Avoiding Common Pitfalls

Do not continue beta‑blockers (e.g., propranolol) for anxiety in the absence of robust efficacy data; continuation delays initiation of evidence‑based psychotherapy. The lack of benefit is supported by systematic reviews. 17
Do not default to specialty mental‑health referral for all anxiety patients; brief CBT delivered within primary care meets the majority of needs and aligns with patient preferences. This approach reduces unnecessary specialist burden. 17
Do not focus solely on symptom scores without assessing functional improvement, as functional recovery is the primary goal of anxiety treatment in primary care. Functional outcomes are emphasized in guideline recommendations. 16
Do not postpone treatment modification beyond 6–8 weeks when response criteria are not met, as delayed escalation prolongs illness and reduces overall effectiveness. Timely adjustment is a key quality metric. 16

All statements are derived from peer‑reviewed evidence cited as 16 and 17, reflecting current best practices for anxiety management in primary‑care settings.

Outpatient Management of Acute Panic Attacks in Adults

Immediate Non‑Pharmacologic Management

Guide the patient to perform slow diaphragmatic breathing during an acute episode to counteract hyperventilation and lower autonomic arousal. 18
Prompt the patient to identify and challenge catastrophic thoughts (e.g., “I’m dying,” “I’m losing control”) that amplify panic symptoms. 19

First‑Line Psychological Treatment

Offer cognitive‑behavioral therapy (CBT) as the initial therapeutic intervention for panic attacks and panic disorder; CBT has the highest level of evidence among anxiety‑disorder treatments. 20
Core CBT components for panic disorder include: psychoeducation about panic physiology, self‑monitoring of triggers, relaxation training, cognitive restructuring of catastrophic cognitions, graduated exposure to feared situations, and interoceptive exposure to feared bodily sensations. 19
In primary‑care settings, ≈66 % of psychological interventions for anxiety demonstrate symptom reduction, and ≈78 % of those maintain treatment gains at follow‑up, indicating robust effectiveness of brief CBT programs. 21

Pharmacologic Treatment Recommendations

Paroxetine and fluoxetine are the SSRIs with the strongest evidence for treating panic disorder and should be used as first‑line pharmacotherapy when medication is indicated. 20
After achieving remission, continue the selected antidepressant for 9–12 months (or longer if needed) to minimize relapse risk. 20

Screening and Comorbidity Assessment

Systematically screen adults presenting with panic attacks for co‑occurring depression, substance‑use disorders, and agoraphobia, as these conditions frequently coexist and require concurrent management. 20